 |
|
|
| |
Effectiveness of Elbasvir/Grazoprevir in Patients With Chronic Hepatitis C and Chronic Kidney Disease:Results From the Veterans Affairs System
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017.
Jennifer R. Kramer1,2; Amy Puenpatom3; Kevin Erickson1,2; Yumei Cao1; Donna L. Smith1,2; Hashem B. El-Serag1,2; Fasiha Kanwal1,2
1Michael E. DeBakey VA Medical Center, Houston, TX, USA; 2Baylor College of Medicine, Houston, TX, USA; 3Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
